The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress
Open accessAbstract
Oxidative stress and enhanced lipid peroxidation are linked to many chronic inflammatory diseases, including age-related macular degeneration (AMD). AMD is the leading cause of blindness in Western societies, but its aetiology remains largely unknown. Malondialdehyde (MDA) is a common lipid peroxidation product that accumulates in many pathophysiological processes, including AMD. Here we identify complement factor H (CFH) as a major MDA-binding protein that can block both the uptake of MDA-modified proteins by macrophages and MDA-induced proinflammatory effects in vivo in mice. The CFH polymorphism H402, which is strongly associated with AMD, markedly reduces the ability of CFH to bind MDA, indicating a causal link to disease aetiology. Our findings provide important mechanistic insights into innate immune responses to oxidative stress, which may be exploited in the prevention of and therapy for AMD and other chronic inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oxidative stress adducts and components of the complement system have been found to accumulate in drusen and sub-RPE deposits of patients with AMD (Weismann et al., 2011; Shaw et al., 2012), and mice with mutations making them prone to oxidative stress or dysregulation of the complement pathway have been presented as models of AMD (Imamura et al., 2006; Justilien et al., 2007; Hollyfield et al., 2”
From Microtubule motors transport phagosomes in the RPE, and lack of KLC1 leads to AMD-like pathogenesis (2015) · cites this paper as Weismann et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
A blast from the past: clearance of apoptotic cells regulates immune responses
Savill, J., Dransfield, I., Gregory, C. D., & Haslett, C. (2002) · Nature reviews. Immunology · doi:10.1038/nri957 · Cited by 1,574
Age-related macular degeneration
Jager, R. D., Mieler, W. F., & Miller, J. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801537 · Cited by 1,379
Complement regulators and inhibitory proteins
Zipfel, P. F., & Skerka, C. (2009) · Nature reviews. Immunology · doi:10.1038/nri2620 · Cited by 1,268
Age-related macular degeneration
de Jong, P. T. V. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062326 · Cited by 787
Age-related Macular Degeneration Histopathologic Studies
Green, W. R., & Enger, C. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31466-1 · Cited by 757
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 533
Rouhollahi, E., Moghadamtousi, S. Z., Hamdi, O. A. A., Fadaeinasab, M., Hajrezaie, M., Awang, K., Looi, C. Y., Abdulla, M. A., & Mohamed, Z. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-378 · Cited by 44
“An effective indicator of oxidative stress and mucosal injuries by ROS is malondialdehyde (MDA), which is a major metabolite of lipid peroxidation [44].”
Backgroundde Córdoba, S. R. (2022) · Immunological Reviews · doi:10.1111/imr.13131 · Cited by 48
He, L., Yang, X., Xu, K., & Lin, W. (2017) · Chemical Communications · doi:10.1039/c7cc00512a · Cited by 43
Drusen maculopathy: a risk factor for visual deterioration
Algvere, P. V., Kvanta, A., & Seregard, S. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13011 · Cited by 44
“Malondialdehyde (MDA) is a common lipid peroxidation product, and CFH is a major MDA-binding protein protecting the outer retina from oxidative stress (Weismann et al. 2011).”
BackgroundGeng, X., Du, X., Wang, W., Zhang, C., Liu, X., Qu, Y., Zhao, M., Li, W., Zhang, M., Tu, K., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c12075 · Cited by 42
Aberrant Lipid Metabolism and Complement Activation in Age-Related Macular Degeneration
Tang, S., Yang, J., Xiao, B., Wang, Y., Lei, Y., Lai, D., & Qiu, Q. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.12.20 · Cited by 48
“161 Notably, CFHR1 binds to MDA-rich areas via SCR1-2, 163 obstructing CFH from inactivating C3b and consequently enhancing the alternative pathway activation.”
BackgroundInfluentialLi, S., Gaur, U., Chong, C., Lin, S., Fang, J., Zeng, Z., Wang, H., & Zheng, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061736 · Cited by 41
“Although the mechanisms behind the origin and development of AMD are not fully understood, increasing studies have indicated that chronic inflammation, oxidative stress, and apoptosis might have an important role in the development of dry AMD [7,8].”
BackgroundMenghini, M., Kloeckener‐Gruissem, B., Fleischhauer, J. C., Kurz-Levin, M. M., Sutter, F. K. P., Berger, W., & Barthelmes, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042014 · Cited by 41
“Alternatively, genetic variations might also account for a different AMD ‘‘phenotype’’ with a different composition of the lesion less susceptible to the approved therapies [34].”
BackgroundAge-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?
Warwick, A., Khandhadia, S., Ennis, S., & Lotery, A. J. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041234 · Cited by 42
“However, this effect was diminished with the CFH H402 variant [69].”
C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration
Molins, B., Romero‐Vázquez, S., Fuentes‐Prior, P., Adán, A., & Dick, A. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00808 · Cited by 43
“MDA is a toxic by-product of lipid peroxidation and Weismann et al. showed that FH binds MDA through SCR7 and protects from oxidative stress.”
BackgroundRole of complement system in pathological remodeling of the vascular wall
Martı́n-Ventura, J. L., Martínez-López, D., Roldán-Montero, R., Gómez‐Guerrero, C., & Blanco‐Colio, L. M. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.06.016 · Cited by 42
Alić, L., Papac-Miličević, N., Czamara, D., Rudnick, R. B., Ozsvár-Kozma, M., Hartmann, A., Gurbisz, M., Hoermann, G., Haslinger-Hutter, S., Zipfel, P. F., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913970117 · Cited by 41
“On the other hand, an impaired removal of MDA-carrying metabolic waste will promote inflammation (14, 19, 22).”
BackgroundMethodResultInfluentialKarlstetter, M., & Langmann, T. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3209-8_27 · Cited by 41
Geographic Atrophy in Age-Related Macular Degeneration
Keenan, T. D. L. (2023) · Ophthalmology Science · doi:10.1016/j.xops.2023.100306 · Cited by 40
“Malondialdehyde is a common lipid peroxidation product that accumulates in many pathophysiological processes, including AMD; it is an important source of oxidative stress and of enhanced complement activation.(62) CFH is a major MDA-binding protein that is thought to block the uptake of MDA-modified proteins by macrop…”
BackgroundKurzawa‐Akanbi, M., Tzoumas, N., Corral-Serrano, J. C., Guarascio, R., STEEL, D. H., Cheetham, M. E., Armstrong, L., & Lako, M. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101248 · Cited by 41
Aredo, B., Li, T., Chen, X., Zhang, K., Wang, C. X.-Z., Gou, D., Zhao, B., He, Y.-G., & Ufret-Vincenty, R. L. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-16089 · Cited by 41
“We propose that the SCR 6-to-8 variant in the chCfhTg mice may be disrupting the delicate balance between MDA–Cfh versus MDA–PRR interactions.(20) This would explain our observations in aging chCfhTg mice of (1) decreased regulation of complement activation and (2) increased microglial/macrophage activation.”
BackgroundInfluentialPotential influences of complement factor H in autoimmune inflammatory and thrombotic disorders
Ferluga, J., Kouser, L., Murugaiah, V., Sim, R. B., & Kishore, U. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.01.015 · Cited by 43
Anaphylatoxins Activate Ca2+, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment Epithelium
Busch, C., Annamalai, B., Abdusalamova, K., Reichhart, N., Huber, C., Lin, Y., Jo, E. A. H., Zipfel, P. F., Skerka, C., Wildner, G., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00703 · Cited by 40
“The ability of the RPE to modulate complement activation on its cell surface, preventing a lytic as well as rapidly terminating a sub-lytic MAC attack, is due to the RPE expressing or recruiting various complement inhibitors to its cell surface (18) and is supported by our recent findings demonstrating that normal hum…”
Lin, L., Liu, X., & Zhao, M. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.09.024 · Cited by 40
Antioxidant Effects of Caffeic Acid Lead to Protection of Drosophila Intestinal Stem Cell Aging
Sheng, X., Zhu, Y., Zhou, J., Yan, L., Du, G., Liu, Z., & Chen, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.735483 · Cited by 42
Schnabolk, G., Parsons, N., Obert, E., Annamalai, B., Nasarre, C., Tomlinson, S., Lewin, A. S., & Rohrer, B. (2017) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.003 · Cited by 43
Mullins, R. F., McGwin, G., Searcey, K., Clark, M. E., Kennedy, E. L., Curcio, C. A., Stone, E. M., & Owsley, C. J. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.10.037 · Cited by 40
Liu, Y., Wang, M., Xu, W. L., Zhang, H., Qian, W., Li, X., & Cheng, X. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117086 · Cited by 39
Complement inhibitors for age-related macular degeneration
Tzoumas, N., Riding, G., Williams, M. A., & Steel, D. H. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009300.pub3 · Cited by 38
Supramolecular erythrocytes-hitchhiking drug delivery system for specific therapy of acute pneumonia
Li, J., Ding, Y., Cheng, Q., Cheng, G., Wei, J., Wang, Z., Huang, Q., & Wang, R. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.029 · Cited by 38
Age-Related Macular Degeneration: Cellular and Molecular Signaling Mechanisms
Jiang, F., Ma, J., Lei, C., Zhang, Y., & Zhang, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136174 · Cited by 44
“The CFH H402 variant also disrupts MDA binding and lipid metabolism [43], as demonstrated in aged mice fed high-fat diets that develop AMD-like pathology with genotype-dependent lipoprotein dysregulation in ocular tissues and plasma [61].”
Complement Factor H-Related 3 Enhanced Inflammation and Complement Activation in Human RPE Cells
Schäfer, N., Rasras, A. J., Ceteras, D., Amslinger, S., Enzmann, V., Jägle, H., & Pauly, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.769242 · Cited by 40
“OSE can trigger inflammation in the retina, which was inhibited by FH binding (17, 18).”
Molecular Genetic Mechanisms in Age-Related Macular Degeneration
Shughoury, A., Sevgi, D. D., & Ciulla, T. A. (2022) · Genes · doi:10.3390/genes13071233 · Cited by 42
“Beyond its immunomodulatory roles, it has also been suggested that CFH may independently act as a protective antioxidant in the RPE [86,87] and play key roles in lipid metabolism [88,89].”
BackgroundSethi, S. M., Fervenza, F. C., Zhang, Y., & Smith, R. J. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.04.011 · Cited by 37
Qiang, M., Xu, Y., Lu, Y. Y., He, Y., Han, C., Liu, Y. M., & He, R. (2014) · Protein & Cell · doi:10.1007/s13238-014-0052-1 · Cited by 37
“Malondialdehyde is an active modifying agent of proteins both in vitro and in vivo (Foettinger et al., 2006; Weismann et al., 2011), causing protein aggregation and amyloid deposition (Allen et al.”
BackgroundPaun, C. C., Lechanteur, Y. T. E., Groenewoud, J. M. M., Altay, L., Schick, T., Daha, M. R., Fauser, S., Hoyng, C. B., den Hollander, A. I., & de Jong, E. K. (2016) · Scientific Reports · doi:10.1038/srep26568 · Cited by 37
Jensen, E. G., Jakobsen, T. S., Thiel, S., Askou, A. L., & Corydon, T. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249752 · Cited by 40
“This increase has been found to affect the expression of complement components in aging and AMD-diseased individuals [87,88,124].”
BackgroundHussein, M. A., Ismail, N. E. M., Mohamed, A., Borik, R. M. A., Ali, A., & Mosaad, Y. O. (2021) · Bioinformatics and Biology Insights · doi:10.1177/11779322211055891 · Cited by 42
Systems genomics in age-related macular degeneration
den Hollander, A. I., Mullins, R. F., Orozco, L. D., Voigt, A. P., Chen, H.-H., Strunz, T., Graßmann, F., Haines, J. L., Kuiper, J. J. W., Tumminia, S. J., et al. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109248 · Cited by 38
Complement pathway biomarkers and age-related macular degeneration
Gemenetzi, M. K., & Lotery, A. J. (2015) · Eye · doi:10.1038/eye.2015.203 · Cited by 39
Stolwijk, J. M., Stefely, J. A., Veling, M. T., Erve, T. J. V. ‘., Wagner, B. A., Raife, T. J., & Buettner, G. R. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102073 · Cited by 36
“This included an anti-correlation with complement factor H (CFH), which directly binds lipid peroxidation-generated malondialdehyde epitopes [31].”
BackgroundRam, S., Shaughnessy, J., DeOliveira, R. B., Lewis, L. A., Gulati, S., & Rice, P. A. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.05.016 · Cited by 35
Hyvärinen, S., Uchida, K., Varjosalo, M. T., Jokela, R., & Jokiranta, T. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.527416 · Cited by 35
“In this context, our finding of altered binding of FH19 –20 to MDA-modified BSA because of several aHUS-related mutations (Fig.”
BackgroundMethodInfluentialBaek, J., Lim, D., Park, K. H., Chae, J., Jang, H., Lee, J., & Chung, H. (2018) · BMC Ophthalmology · doi:10.1186/s12886-018-0941-9 · Cited by 36
Yang, Y. X., Kong, F., Ding, Q., Cai, Y., Hao, Y., & Tang, B. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.097 · Cited by 35
Oxidation-specific epitopes as targets for biotheranostic applications in humans
Miller, Y. I., & Tsimikas, S. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328364e85a · Cited by 34
“It was also demonstrated that CFH and MDA co-localize in human atheroma from patients with acute coronary syndromes (Fig.”
BackgroundInfluentialMaugeri, A., Barchitta, M., Mazzone, M. G., Giuliano, F., & Agodi, A. (2018) · BioMed Research International · doi:10.1155/2018/7532507 · Cited by 34
“Pathological features of AMD are caused by the interaction of oxidative stress, impaired RPE activity and function, increased apoptosis, and abnormal immune system activation [4, 5].”
BackgroundZhang, J., Liu, X., Pan, J., Zhao, Q., Li, Y., Gao, W., & Zhang, Z. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103724 · Cited by 34
Characterization of Binding Properties of Individual Functional Sites of Human Complement Factor H
Haque, A., Cortés, C., Alam, M. N., Sreedhar, M., Ferreira, V. P., & Pangburn, M. K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01728 · Cited by 33
“Control of complement activation on host tissues involves interactions of Factor H with surface-bound C3b, iC3b, C3d, with polyanionic host markers (4, 6, 8) and with malondialdehyde (MDA)-modified lipids or proteins (9).”
BackgroundOxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease
Hendrikx, T., & Binder, C. J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.607011 · Cited by 35
“In addition, our group has shown that genetic variants of one of theMDA-binding sites of CFH influence the capacity of CFH to bindMDA (81).”
BackgroundInvestigational drugs in clinical trials for macular degeneration
Tolentino, M. J., & Tolentino, A. J. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2113375 · Cited by 34
“The Y402H polymorphism reduces binding of MDA allowing this oxidative byproduct to initiate and propagate complement mediated inflammation [38].”
BackgroundAssociation Between Age-Related Decline of Kidney Function and Plasma Malondialdehyde
Li, G., Chen, Y., Hu, H., Liu, L., Hu, X., Wang, J., Shi, W., & Yin, D. (2012) · Rejuvenation Research · doi:10.1089/rej.2011.1259 · Cited by 34
Sofat, R., Mangione, P. P., Gallimore, J. R., Hakobyan, S., Hughes, T. R., Shah, T., Goodship, T. H. J., D’Aiuto, F., Langenberg, C., Wareham, N. J., et al. (2013) · Journal of Immunological Methods · doi:10.1016/j.jim.2013.01.009 · Cited by 34
Cytotoxicity of All‐Trans‐Retinal Increases Upon Photodegradation†
Rôżanowska, M., Handzel, K. E., Boulton, M. E., & Różanowski, B. (2012) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2012.01161.x · Cited by 35
“(MDA), a small aldehyde derived from peroxidation of lipids, and this way protecting from its deleterious effects (48).”
BackgroundTzoumas, N., Hallam, D., Harris, C. L., Lako, M., Kavanagh, D., & Steel, D. H. W. (2021) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2020.10.008 · Cited by 33
Muri, J., Feng, Q., Wolleb, H., Shamshiev, A. T., Ebner, C., Tortola, L., Brož, P., Carreira, E. M., & Köpf, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.019 · Cited by 34
“, 2002), complement factors (Weismann et al., 2011), and natural antibodies (Palinski et al.”
BackgroundMolecular Basis of Factor H R1210C Association with Ocular and Renal Diseases
Recalde, S., Tortajada, A., Subias, M., Anter, J., Blasco, M., Maranta, R., Coco, R., Pinto, S., Noris, M., García-Layana, A., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050580 · Cited by 32
“In this respect, it has been reported that the AMD risk FH-402H variant fails to bind a number of ligands, including CRP, heparan sulfate and malondialdehyde, a common lipid peroxidation product found in the aged retina and implicated in AMD (24-26).”
BackgroundAge-related macular degeneration
de Jong, E. K., Geerlings, M. J., & den Hollander, A. I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816222-4.00010-1 · Cited by 32
Bruch’s Membrane and the Choroid in Age-Related Macular Degeneration
Edwards, M., & Lutty, G. A. (2021) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-66014-7_4 · Cited by 32
An Overview of Ischemia–Reperfusion Injury: Review on Oxidative Stress and Inflammatory Response
Güler, M. C., Tanyeli̇, A., Akdemi̇r, F. N. E., Eraslan, E., Şebin, S. Ö., Güzel, D., & Nacar, T. (2023) · Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2022.22293 · Cited by 35
Modeling complex age-related eye disease
Becker, S., L'Ecuyer, Z., Jones, B. W., Zouache, M. A., McDonnell, F. S., & Vinberg, F. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101247 · Cited by 34
The role of oxidized phospholipids in the development of disease
Nie, J. S., Yang, J., Wei, Y., & Wei, X. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100909 · Cited by 33
Function and Dysfunction of Complement Factor H During Formation of Lipid-Rich Deposits
Meri, S., & Haapasalo, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.611830 · Cited by 32
“Both the Y402H polymorphism in domain seven, and atypical hemolytic uremic syndrome (aHUS) associated mutations in domains 19–20 impair this interaction (70, 71).”
BackgroundBuonfiglio, F., Korb, C. A., Stoffelns, B. M., Pfeiffer, N., & Gericke, A. (2024) · Aging and Disease · doi:10.14336/ad.2024.0124 · Cited by 35
“Importantly, the Y402H variant disrupts lipid metabolism in RPE cells due to the disability of CFH to bind oxidative byproducts, such as OxLDLs and MDA [335-337].”
Sex Disparities of Genomic Determinants in Response to Immune Checkpoint Inhibitors in Melanoma
Shi, F., Zhang, W., Yang, Y., Yang, Y., Zhao, J., Xie, M., Sheng, C., Wang, S., & Wang, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.721409 · Cited by 31
Genetic factors associated with the development of age-related macular degeneration
Sergejeva, O., Botov, R., Liutkevičienė, R., & Kriaučiūnienė, L. (2016) · Medicina · doi:10.1016/j.medici.2016.02.004 · Cited by 31
Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics
Ram, S., Shaughnessy, J., DeOliveira, R. B., Lewis, L. A., Gulati, S., & Rice, P. A. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx049 · Cited by 30
“(402H) decreases the binding of FH tomalondialdehydes that accumulates in drusen (Weismann et al. 2011), the retinal lesions that characterize the dry form of age-related macular degeneration, thereby permitting relatively uninhibited alternative path-”
BackgroundGenetic Aspects of Age-Related Macular Degeneration and Their Therapeutic Potential
Stradiotto, E., Allegrini, D., Fossati, G., Raimondi, R., Sorrentino, T., Tripepi, D., Barone, G., Inforzato, A., & Romano, M. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113280 · Cited by 29
“This mechanism further links oxidative, lipid, and complement dysregulation in AMD [61].”
BackgroundZhao, Q., & Lai, K. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109770 · Cited by 31
Wong, S. M. S., Shaughnessy, J., Ram, S., & Akerley, B. J. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00040 · Cited by 29
“Data were acquired on a BD FACSCalibur flow cytometer and data were analyzed using FlowJo software.”
BackgroundMethodRudnick, R. B., Chen, Q., Stea, E. D., Hartmann, A., Papac-Miličević, N., Person, F., Wiesener, M. S., Binder, C. J., Wiech, T., Skerka, C., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701641 · Cited by 29
“As MAA-bound factor H inhibits complement, we asked whether FHR5 activates complement on this specific surface (31).”
BackgroundInfluentialSerum levels of lipid metabolites in age‐related macular degeneration
Orban, T., Johnson, W. M., Dong, Z., Maeda, T., Maeda, A., Sakai, T., Tsuneoka, H., Mieyal, J. J., & Palczewski, K. (2015) · The FASEB Journal · doi:10.1096/fj.15-275289 · Cited by 29
“Oxidative stress by-products such as malonaldehyde and 4-hydroxy-2nonenal were also found to be elevated in patients with AMD (69).”
BackgroundXu, X., & Kim, S. K. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003108 · Cited by 29
Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis
Hoebinger, C., Rajcic, D., & Hendrikx, T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.824481 · Cited by 32
The human factor H protein family – an update
Sándor, N., Schneider, A. E., Matola, A. T., Barbai, V. H., Bencze, D., Hammad, H. H., Papp, A., Kövesdi, D., Uzonyi, B., & Józsi, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1135490 · Cited by 29
Organisciak, D., Wong, P., Rapp, C., Darrow, R., Ziesel, A., Rangarajan, R., & Lang, J. C. (2012) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2012.01134.x · Cited by 29
“CFH is also a major serum binding protein for MDA, a common lipid oxidation product (31), which would be expected to further reduce oxidative stress.”
Friedli, O., & Freigang, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.07.006 · Cited by 28
Evidence that endogenous formaldehyde produces immunogenic and atherogenic adduct epitopes
Nakamura, J., Shimomoto, T., Collins, L. B., Holley, D., Zhang, Z., Barbee, J., Sharma, V., Tian, X., Kondo, T., Uchida, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11289-8 · Cited by 28
“Although MDA is less reactive compared to α, β-unsaturated aldehydes produced by lipid peroxidation, MDA has the unique property of modifying macromolecules through (1) simple mono-adduction4, (2) crosslinkage5, and (3) hybrid adduct formation in the presence of other aldehydes4.”
Saeed, A. M., Duffort, S., Ivanov, D., Wang, H., Laird, J. M., Salomon, R. G., Cruz‐Guilloty, F., & Perez, V. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106421 · Cited by 27
“MDA has been implicated in the pathogenesis of both AMD and atherosclerosis [9].”
BackgroundChu, Q., Jia, R., Chen, W., Liu, Y., Li, Y., Ye, X., Jiang, Y., & Zheng, X. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.10.128 · Cited by 27
Mulfaul, K., Mullin, N. K., Giacalone, J. C., Voigt, A. P., DeVore, M., Stone, E. M., Tucker, B. A., & Mullins, R. F. (2022) · The Journal of Pathology · doi:10.1002/path.5867 · Cited by 31
Ananth, S., Babu, E., Veeranan‐Karmegam, R., Baldowski, B. R. B., Boettger, T., & Martin, P. M. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11289 · Cited by 27
Defence against oxidative damage
Cruz‐Guilloty, F., & Perez, V. L. (2011) · Nature · doi:10.1038/478042a · Cited by 27
Evidence of complement dysregulation in outer retina of Stargardt disease donor eyes
Hu, J. G., Pauer, G. J. T., Hagstrom, S. A., Bok, D., DeBenedictis, M. J., Bonilha, V. L., Hollyfield, J. G., & Radu, R. A. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101787 · Cited by 26
High Myopia and the Complement System: Factor H in Myopic Maculopathy
García-Gen, E., Penadés, M., Mérida, S., Desco, C., Araújo-Miranda, R., Návea, A., & Bosch‐Morell, F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122600 · Cited by 26
“CFH also blocks the proinflammatory effects of malondialdehyde, a majority lipid peroxidation product, and protects from oxidative stress in vivo in mice [46,47].”
BackgroundCommon and rare genetic variants of complement components in human disease
de Jorge, E. G., López‐Lera, A., Bayarri‐Olmos, R., Yébenes, H., López‐Trascasa, M., & de Córdoba, S. R. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.011 · Cited by 25
de Córdoba, S. R. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.05.015 · Cited by 27
Loeven, M. A., Rops, A. L. W. M. M., Berden, J. H. M., Daha, M. R., Rabelink, T. J., & van der Vlag, J. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.08.005 · Cited by 27
Guo, W., Cui, S., Tang, X., Yan, Y., Xiong, F., Zhang, Q., Zhao, J., Mao, B., & Zhang, H. (2023) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12665 · Cited by 24
Patil, H., Saha, A., Senda, E., Cho, K.-I., Haque, M., Yu, M., Qiu, S., Yoon, D., Hao, Y., Peachey, N. S., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.586834 · Cited by 25
Ma, M., Chen, X., Gu, C., Xiao, X., Guo, T., & Li, B. (2014) · Europe PMC (PubMed Central) · Cited by 25
Lim, S. H., Kim, Y., Yun, K. N., Kim, J. Y., Jang, J., Han, M., & Lee, J. (2016) · Scientific Reports · doi:10.1038/srep38728 · Cited by 25
Pujol-Lereis, L. M., Liebisch, G., Schick, T., Lin, Y.-C., Graßmann, F., Uchida, K., Zipfel, P. F., Fauser, S., Skerka, C., & Weber, B. H. F. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200739 · Cited by 27
Liu, S., Guo, B., Gao, Q., Deng, Y.-J., Yan, B., Yin, Z., Zhao, M., Ren, K., Wang, F., & Guo, J. (2023) · Phytotherapy Research · doi:10.1002/ptr.8034 · Cited by 24
“MDA levels are hallmarks of lipid peroxidation, and SOD levels represent the body's antioxidant capacity (Weismann et al., 2011).”
BackgroundMosses: Versatile plants for biotechnological applications
Campos, M. L., Prado, G. S., dos Santos, V. O., Nascimento, L. C., Dohms, S. M., da Cunha, N. B., Ramada, M. H. S., Grossi‐de‐Sá, M. F., & Dias, S. C. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107533 · Cited by 24
Immunological Aspects of Age-Related Macular Degeneration
Allingham, M. J., Loksztejn, A., Cousins, S. W., & Mettu, P. S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-66014-7_6 · Cited by 25
Antibodies in action: the role of humoral immunity in the fight against atherosclerosis
Taylor, J. A., Hutchinson, M. A., Gearhart, P. J., & Maul, R. W. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00316-6 · Cited by 24
Zhang, P., Zhu, M., Geng-Spyropoulos, M., Shardell, M. D., González‐Freire, M., Gudnason, V. G., Eiríksdóttir, G., Schaumberg, D. A., Eyk, J. E. V., Ferrucci, L., et al. (2016) · PROTEOMICS · doi:10.1002/pmic.201600237 · Cited by 24
Shinojima, A., Sawa, M., Sekiryu, T., Oshima, Y., Mori, R., Hara, C., Sugano, Y., Kato, A., Asato, H., Yuzawa, M., et al. (2017) · Ophthalmologica · doi:10.1159/000455807 · Cited by 24
Reiner, A. P., Hartiala, J., Zeller, T., Bis, J. C., Dupuis, J., Fornage, M., Baumert, J. J., Kleber, M. E., Wild, P. S., Baldus, S. E., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt189 · Cited by 23
Ljubisavljević, S., Stojanović, I. R., Pavlovic, D. D., Milojković, M., Sokolovic, D. T., Stevanović, I. D., & Petrovic, A. (2013) · Folia Neuropathologica · doi:10.5114/fn.2013.34196 · Cited by 23
Rohrer, B., Frazer‐Abel, A. A., Leonard, A. P., Ratnapriya, R., Ward, T., Pietraszkiewicz, A. A., O’Quinn, E. C., Adams, K., Swaroop, A., & Wolf, B. J. (2019) · Europe PMC (PubMed Central) · Cited by 23
Herrmann, P., Cowing, J. A., Cristante, E., Liyanage, S. E., Ribeiro, J., Durán, Y., Abelleira, L. E., Carvalho, L. S., Bainbridge, J. W., Luhmann, U. F. O., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.05.019 · Cited by 20
“Enhanced local stress or additional triggers for innate immune activation, such as photo-oxidative protein adducts in the retina (Weismann et al., 2011), may also increase local complement dysregulation and ocular pathology.”
Transcriptome Characterization of Short Distance Transport Stress in Beef Cattle Blood
Zhao, H., Tang, X., Wu, M., Li, Q., Yi, X., Liu, S., Jiang, J., Wang, S., & Sun, X. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.616388 · Cited by 22
Li, W., Nie, G., Yang, A., Qu, J., Zhong, C., & Chen, D. (2023) · Talanta · doi:10.1016/j.talanta.2023.124819 · Cited by 22
Metadata
- Authors
- Weismann, D., Hartvigsen, K., Lauer, N., Bennett, K. L., Scholl, H. P. N., Issa, P. C., Cano, M., Brandstätter, H., Tsimikas, S., Skerka, C., Superti-Furga, G., Handa, J. T., Zipfel, P. F., Witztum, J. L., & Binder, C. J.
- Affiliations
- Austrian Academy of Sciences (AT)
- Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) (DE)
- Johns Hopkins University (US)
- University of Oxford (GB)
- Octapharma (Austria) (AT)
- University of California San Diego (US)
- Corresponding author
- Binder, Christoph J.
- ORCID
- Venue
- Nature
- Published
- 2011-10
- Volume
- 478
- Issue
- 7367
- Pages
- 76-81
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4826616
- OpenAlex
- W2062097745
- Cited by
- 533
- References
- 42
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 25 · 2023: 30 · 2022: 29 · 2021: 42 · 2020: 36 · 2019: 29 · 2018: 33 · 2017: 31 · 2016: 39 · 2015: 42 · 2014: 44 · 2013: 66 · 2012: 44
- FWCI
- 22.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01-HL086599, HL-088093, P01HL088093)
- National Eye Institute (EY14005, R01EY014005, EY019044, R01EY019904)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- complement factor H, malondialdehyde, lipid peroxidation, oxidative stress, age-related macular degeneration, macrophage uptake, pro-inflammatory effects, innate immunity, chronic inflammation, retina
- MeSH terms
- Animals, Epitopes, Binding Sites, Complement System Proteins, Complement Inactivator Proteins, Enzyme-Linked Immunosorbent Assay, Female, Humans, Inflammation, Macular Degeneration, Male, Malondialdehyde, Mice, Inbred C57BL, Mutation, Necrosis, Protein Binding, Retina, Lipid Peroxidation, Apoptosis, Complement Factor H, Protein Structure, Tertiary, Macrophages, Peritoneal, Oxidative Stress, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review